Methodology for guideline development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy -: The Seventh ACCP Conference on Antithrombotic and Thrombolytic

被引:25
|
作者
Schünemann, HJ [1 ]
Munger, H [1 ]
Brower, S [1 ]
O'Donnell, M [1 ]
Crowther, M [1 ]
Cook, D [1 ]
Guyatt, G [1 ]
机构
[1] Univ Buffalo, Dept Med, Div Gen Internal Med, Buffalo, NY 14226 USA
关键词
D O I
10.1378/chest.126.3_suppl.174S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This article describes the methodology for the Seventh American College of Chest Physicians (ACCP) Conference on Antithrombotic, and Thrombolytic Therapy: Evidence-Based Guidelines. Guideline authors began by specifying the population, the intervention and alternative, and the outcomes for each clinical question, and defined the criteria for eligible articles, including methodological criteria, for each recommendation. Librarians, in collaboration with guideline authors and methodologists, conducted systematic searches for evidence. Guideline authors systematically evaluated the evidence, considered the full range of benefits, risks, inconvenience, and costs associated with alternative management strategies, considered patients' underlying values and preferences, and made recommendations accordingly. To increase the likelihood that the recommendations adequately represent patient values and preferences, the development process included a review of recommendations by research methodologists, practicing generalists, and specialists. Chapters are organized so that evidence is clearly linked to the relevant recommendations, and that recommendations particularly sensitive to underlying values and preferences are explicitly identified. Authors paid careful attention to the strength of the underlying evidence and to the balance between risks and benefits, which are both reflected in the grades of recommendations. Thus, improvements to the process of making recommendations for the ACCP guidelines include the explicit definition of questions, transparent eligibility criteria for including studies, and the specification of values and preferences underlying recommendations where they are particularly relevant. In combination with our previous practice of grading recommendations according to their strength, and the methodological quality of the supporting studies, these innovations establish our guidelines as, by and large, evidence based.
引用
收藏
页码:174S / 178S
页数:5
相关论文
共 50 条
  • [31] Report of a Consensus Conference of the American College of Chest Physicians
    Make, BJ
    Hill, NS
    Goldberg, AI
    Bach, JR
    Criner, GJ
    Dunne, PE
    Gilmartin, ME
    Heffner, JE
    Kacmarek, R
    Keens, TG
    McInturff, S
    O'Donohue, WJ
    Oppenheimer, EA
    Robert, D
    CHEST, 1998, 113 (05) : 289S - 344S
  • [32] Perioperative Management of Antithrombotic Medications: Guidelines From the American College of Chest Physicians
    du Breuil, Anne L.
    AMERICAN FAMILY PHYSICIAN, 2023, 108 (02) : 208 - 211
  • [33] The seventh American College of Chest Physicians guidelines for the antenatal and peripartum management of thrombophilia: A tutorial
    Blickstein, Dorit
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2006, 33 (03) : 499 - +
  • [34] Guideline conflict of interest management and methodology heavily impacts on the strength of recommendations: comparison between two iterations of the American College of Chest Physicians Antithrombotic Guidelines
    Agoritsas, Thomas
    Neumann, Ignacio
    Mendoza, Carolina
    Guyatt, Gordon H.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017, 81 : 141 - 143
  • [35] Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline (vol 162, pg e207, 2022)
    Douketis, James D.
    Spyropoulos, Alex C.
    Murad, M. Hassan
    Arcelus, Juan, I
    Dager, William E.
    Dunn, Andrew S.
    Fargo, Ramiz A.
    Levy, Jerrold H.
    Samama, C. Marc
    Shah, Sahrish H.
    Sherwood, Matthew W.
    Tafur, Alfonso J.
    Tang, Liang, V
    Moores, Lisa K.
    CHEST, 2023, 164 (01) : 267 - 267
  • [37] ACCP Consensus Conference on Antithrombotic Therapy - Indicate specific low molecular weight heparin product and dosage
    Lobo, BL
    Greene, WL
    CHEST, 1996, 110 (03) : 866 - 866
  • [38] CONSENSUS DEVELOPMENT - THROMBOLYTIC THERAPY IN TREATMENT - SUMMARY OF AN NIH CONSENSUS CONFERENCE
    不详
    BRITISH MEDICAL JOURNAL, 1980, 280 (6231): : 1585 - 1587
  • [39] American College of Chest Physicians (ACCP) survey on the diagnosis and therapy of idiopathic pulmonary fibrosis
    Peikert, Tobias
    Daniels, Craig E.
    Beebe, Timothy J.
    Meyer, Keith C.
    Ryu, Jay H.
    CHEST, 2007, 132 (04) : 585S - 585S
  • [40] Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
    Kearon, Clive
    Akl, Elie A.
    Comerota, Anthony J.
    Prandoni, Paolo
    Bounameaux, Henri
    Goldhaber, Samuel Z.
    Nelson, Michael E.
    Wells, Philip S.
    Gould, Michael K.
    Dentali, Francesco
    Crowther, Mark
    Kahn, Susan R.
    CHEST, 2012, 141 (02) : E419S - +